MRGBP, or MRG/MORF4L-binding protein, is a human protein encoded by the MRGBP gene. It belongs to a family of chromatin-associated proteins that are believed to play roles in regulating gene expression, particularly through the modification of chromatin structure. The MRG domain is a protein interaction interface found in various chromatin regulatory factors, and proteins that contain this domain often participate in transcriptional regulation and chromatin remodeling.MRGBP is known to be a component of the NuA4 (nucleosome acetyltransferase of H4) histone acetyltransferase complex, which is vital for the acetylation of histone proteins, particularly histone H4. This modification of histones is a key regulatory mechanism in the control of gene expression, as it can alter the accessibility of DNA to transcription factors and other proteins that influence transcription. Acetylation typically reduces the positive charge on histones, thereby decreasing their affinity for the negatively charged DNA and allowing for a more relaxed chromatin structure that is permissive to transcription.
Through its association with the NuA4 complex and interaction with MRG domain-containing proteins, MRGBP is implicated in the regulation of multiple genes and is essential for various cellular processes, including cell cycle progression, DNA repair, and differentiation. The protein's precise molecular functions and mechanisms of action in chromatin remodeling and transcriptional regulation are still under investigation.Given its role in modulating gene expression, MRGBP may have implications in cellular transformation and cancer. Aberrations in chromatin remodeling proteins and histone modification patterns are often associated with tumorigenesis, suggesting that MRGBP could potentially be a candidate for further research in cancer biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, potentially affecting chromatin structure and indirectly influencing MRGBP activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, which might impact chromatin remodeling and indirectly affect MRGBP. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, potentially altering chromatin dynamics and indirectly influencing MRGBP. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor, potentially affecting gene regulation mechanisms relevant to MRGBP. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A histone deacetylase inhibitor, which may influence chromatin remodeling and indirectly affect MRGBP. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
An inhibitor of the sirtuin class of deacetylases, possibly impacting chromatin structure and MRGBP function. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective histone deacetylase inhibitor, potentially affecting chromatin architecture and MRGBP activity. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
A histone deacetylase inhibitor, which could indirectly influence chromatin remodeling and MRGBP function. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor, which might have indirect effects on chromatin dynamics and MRGBP. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent histone deacetylase inhibitor, potentially affecting chromatin organization and indirectly MRGBP. | ||||||